Table 1.
Material | Method | LPS Source | Sensitivity, Time | Range | Reference |
---|---|---|---|---|---|
LAL assay | various | various | 0.005–50.0 EU mL−1 (0.0005–5.00 ng mL−1) | [35] | |
Recombinant Factor C and fluorogenic peptide substrate | fluorescence | various | 0.005 EU mL−1 | 0.005–50.0 EU mL−1 | [38] |
Enhanced green fluorescent protein mutant | Fluorescence | E. coli O55:B5 | 5 ng mL−1 | [49] | |
Limulus amebocyte lysate | Quartz crystal microbalance | Endotoxin standard Spiked in human plasma | 0.005 EU mL−1 (0.0005 ng mL−1), 30 min |
0.005–10 EU mL−1 | [50] |
Dye-labeled LPS binding peptide | Fluorescence quenching on graphene oxide | E. coli 0111:B4, Pseudomonas aeruginosa, Salmonella typhosa, and Klebsiella pneumonia | 130 pM (molar mass of 10 kDa assumed), equivalent to 1.3 ng mL−1, 5 min |
0–20 nM, equivalent to 0–20 ng mL−1 | [52] |
Aptamer modified magnetic beads | Flow cytometry/scanning confocal laser microscopy | E. coli O55:B5 | 0.01 ng mL−1 Less than 1 min |
10−2–10−6 ng mL−1 | [54] |
Polymer modified gold nanorods | Localized surface plasmon resonance | Salmonella enterica serotype typhimirium, Escherichia coli 0127:B8 | Ka~107–1010 M−1 for LPS binding to nanorods, depending on polymer | Not reported | [64] |
Cysteamine-modified gold nanoparticles | Localized surface plasmon resonance | E. coli O55:B5 | 0.33 nM, molar mass determined as 10 kDa, equivalent to 3.3 ng mL−1, 5 min |
5–90 nM | [66] |
Superparamagnetic nanoparticles/antibodies | Magnetization | Francisella tularensis | 0.1 ng mL−1, 20–60 min |
0.1–1000 ng mL−1 | [74] |
Array of silver nanocolumns/polymyxin B peptide | Localized surface plasmon resonance | E. coli O111:B4 | 0.34 ng mL−1, 1 h |
[67] | |
Magnetic nanoparticle/dye labeled aptamer | Fluorescence quenching | 35 ng mL−1, 40 min |
50–10,000 ng mL−1 | [80] | |
CdTe quantum dots/Con A | Photoluminescence quenching | S. marcescens (strain ATCC 21639) | 10–90 fg mL−1 | [85] |